Sabinsa Corporation's SelenoForce^® has been granted a European patent (EP 1968620).

SelenoForce^® is a selenium-enriched garlic product manufactured by a soil less culture process. Garlic bulbs are naturally enriched with a unique composition of organic selenium compounds for nutritional supplementation, using a proprietary hydroponics method. The selenium enriched bulbs are dried, powdered and standardized, to yield SelenoForce^® containing 1000 ppm selenium, in bioavailable organic form, in a base of natural garlic powder.

The proven benefits of selenium in the management of cancer and metabolic syndromes including diabetes, cardiovascular disease, inflammation and aging, and to improve cognitive functions and immunity well establish SelenoForce^® as an ideal nutritional supplement for maintaining good health in human beings and animals.

"This truly is the best of both worlds, as Sabinsa addresses the need for garlic and selenium, especially in the aging population," said Dr. Nagabhushanam Kalyanam, Sabinsa's President of R&D. "We're delighted to see such a unique form of selenium supplementation recognized by the European Patent office."

In 2010 Sabinsa Corporation’s New Dietary Ingredient notification for SelenoForce^® to the US FDA was accepted and filed by that agency. The company also holds a US patent on SelenoForce. For more information please visit: www.selenoforce.com